Glenmark Pharmaceuticals has informed that it enclosed Certificate from Practicing Company Secretary under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended 31st March, 2022.
The above information is a part of company’s filings submitted to BSE.